KDM1A and diabetic retinopathy: However, the role of LSD1 has been confirmed in donors with diabetic retinopathy, and its role is different from that of SUV420h2, indicating that targeting LSD1 may be a better potential strategy to slow the progression of diabetic retinopathy than targeting SUV420h2.